ID   NFASC_RAT               Reviewed;        1240 AA.
AC   P97685; P97684; Q91Z60;
DT   14-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   14-NOV-2003, sequence version 2.
DT   02-OCT-2024, entry version 182.
DE   RecName: Full=Neurofascin;
DE   Flags: Precursor;
GN   Name=Nfasc;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   STRAIN=Wistar;
RA   Tait S., Collinson J.M., Brophy P.J.;
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 25-1240 (ISOFORMS 1; 2 AND 3), AND SUBUNIT.
RC   TISSUE=Brain;
RX   PubMed=8947556; DOI=10.1083/jcb.135.5.1355;
RA   Davis J.Q., Lambert S., Bennett V.;
RT   "Molecular composition of the node of Ranvier: identification of ankyrin-
RT   binding cell adhesion molecules neurofascin (mucin+/third FNIII domain-)
RT   and NrCAM at nodal axon segments.";
RL   J. Cell Biol. 135:1355-1367(1996).
RN   [3]
RP   FUNCTION OF ISOFORMS 2/3.
RX   PubMed=9562181;
RX   DOI=10.1002/(sici)1098-1136(199805)23:1<11::aid-glia2>3.0.co;2-7;
RA   Collinson J.M., Marshall D., Gillespie C.S., Brophy P.J.;
RT   "Transient expression of neurofascin by oligodendrocytes at the onset of
RT   myelinogenesis: implications for mechanisms of axon-glial interaction.";
RL   Glia 23:11-23(1998).
RN   [4]
RP   FUNCTION OF ISOFORMS 1 AND 2/3, INDIRECT ASSOCIATION WITH CNTNAP1,
RP   PHOSPHORYLATION, AND TISSUE SPECIFICITY.
RX   PubMed=10931875; DOI=10.1083/jcb.150.3.657;
RA   Tait S., Gunn-Moore F., Collinson J.M., Huang J., Lubetzki C., Pedraza L.,
RA   Sherman D.L., Colman D.R., Brophy P.J.;
RT   "An oligodendrocyte cell adhesion molecule at the site of assembly of the
RT   paranodal axo-glial junction.";
RL   J. Cell Biol. 150:657-666(2000).
RN   [5]
RP   INTERACTION WITH SCN1B AND SCN3B.
RX   PubMed=11470829; DOI=10.1083/jcb.200102086;
RA   Ratcliffe C.F., Westenbroek R.E., Curtis R., Catterall W.A.;
RT   "Sodium channel beta1 and beta3 subunits associate with neurofascin through
RT   their extracellular immunoglobulin-like domain.";
RL   J. Cell Biol. 154:427-434(2001).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH GLDN.
RX   PubMed=16039564; DOI=10.1016/j.neuron.2005.06.026;
RA   Eshed Y., Feinberg K., Poliak S., Sabanay H., Sarig-Nadir O., Spiegel I.,
RA   Bermingham J.R. Jr., Peles E.;
RT   "Gliomedin mediates Schwann cell-axon interaction and the molecular
RT   assembly of the nodes of Ranvier.";
RL   Neuron 47:215-229(2005).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1174; SER-1187 AND SER-1190,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-752 AND ASN-1015, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=24090084; DOI=10.1021/pr400783j;
RA   Parker B.L., Thaysen-Andersen M., Solis N., Scott N.E., Larsen M.R.,
RA   Graham M.E., Packer N.H., Cordwell S.J.;
RT   "Site-specific glycan-peptide analysis for determination of N-glycoproteome
RT   heterogeneity.";
RL   J. Proteome Res. 12:5791-5800(2013).
CC   -!- FUNCTION: Cell adhesion, ankyrin-binding protein which may be involved
CC       in neurite extension, axonal guidance, synaptogenesis, myelination and
CC       neuron-glial cell interactions. Isoform 2/isoform 3 may be responsible
CC       for mediating and signaling axon-glial interaction during the early
CC       stages of myelination. {ECO:0000269|PubMed:10931875,
CC       ECO:0000269|PubMed:16039564, ECO:0000269|PubMed:9562181}.
CC   -!- SUBUNIT: Horseshoe-shaped homodimer (By similarity). Probable
CC       constituent of a NFASC/NRCAM/ankyrin G complex. Associates with the
CC       sodium channel beta-1 (SCN1B) and beta-3 (SCN3B) subunits. Associates
CC       to subunit beta-1 in developing axons as early as postanatal day 5,
CC       during the period that nodes of Ranvier are forming. Isoform 2/isoform
CC       3 is likely to interact with axonal proteins in close association with
CC       CNTNAP1. Interacts with GLDN/gliomedin. Interacts with MYOC (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Note=Isoform 1 colocalizes with ankyrin G at the nodes of
CC       Ranvier. Isoform 2/ isoform 3 is a glial component of the paranodal
CC       axo-glial junction.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=NF186, 186 kDa isoform;
CC         IsoId=P97685-1; Sequence=Displayed;
CC       Name=2; Synonyms=NF155, 155 kDa isoform;
CC         IsoId=P97685-2; Sequence=VSP_050416, VSP_050417, VSP_050418,
CC                                  VSP_050419;
CC       Name=3; Synonyms=NF155, 155 kDa isoform;
CC         IsoId=P97685-3; Sequence=VSP_050416, VSP_050417, VSP_008941,
CC                                  VSP_050418, VSP_050419;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is expressed at Nodes of Ranvier while
CC       isoform 2/isoform 3 is expressed in unmyelinated axons.
CC       {ECO:0000269|PubMed:10931875}.
CC   -!- DEVELOPMENTAL STAGE: Strongly but transiently up-regulated in
CC       oligodendrocytes at the onset of myelinogenesis. Once these last have
CC       engaged their target exons, expression declines precipitously.
CC   -!- DOMAIN: Homophilic adhesion is primarily mediated by the interaction of
CC       the second Ig-like domains. {ECO:0000250}.
CC   -!- PTM: Isoform 2/isoform 3 is phosphorylated at P12. Dephosphorylation is
CC       required for ankyrin binding. {ECO:0000269|PubMed:10931875}.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily.
CC       L1/neurofascin/NgCAM family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY061639; AAL27854.1; -; mRNA.
DR   EMBL; U81035; AAB47753.1; -; mRNA.
DR   EMBL; U81036; AAB47754.1; -; mRNA.
DR   RefSeq; NP_001153785.1; NM_001160313.1.
DR   RefSeq; NP_001153786.1; NM_001160314.1. [P97685-1]
DR   RefSeq; NP_446361.1; NM_053909.2.
DR   PDB; 7XCE; X-ray; 2.50 A; A=1187-1214.
DR   PDBsum; 7XCE; -.
DR   AlphaFoldDB; P97685; -.
DR   SMR; P97685; -.
DR   BioGRID; 250572; 6.
DR   IntAct; P97685; 1.
DR   MINT; P97685; -.
DR   STRING; 10116.ENSRNOP00000057594; -.
DR   GlyCosmos; P97685; 12 sites, No reported glycans.
DR   GlyGen; P97685; 12 sites, 1 N-linked glycan (2 sites).
DR   iPTMnet; P97685; -.
DR   PhosphoSitePlus; P97685; -.
DR   SwissPalm; P97685; -.
DR   jPOST; P97685; -.
DR   PaxDb; 10116-ENSRNOP00000057594; -.
DR   ABCD; P97685; 1 sequenced antibody.
DR   GeneID; 116690; -.
DR   KEGG; rno:116690; -.
DR   UCSC; RGD:620911; rat. [P97685-1]
DR   AGR; RGD:620911; -.
DR   CTD; 23114; -.
DR   RGD; 620911; Nfasc.
DR   VEuPathDB; HostDB:ENSRNOG00000030515; -.
DR   eggNOG; KOG3513; Eukaryota.
DR   InParanoid; P97685; -.
DR   OrthoDB; 2912783at2759; -.
DR   PhylomeDB; P97685; -.
DR   TreeFam; TF351098; -.
DR   Reactome; R-RNO-447043; Neurofascin interactions.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   PRO; PR:P97685; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Bgee; ENSRNOG00000030515; Expressed in cerebellum and 10 other cell types or tissues.
DR   ExpressionAtlas; P97685; baseline and differential.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0043194; C:axon initial segment; IDA:BHF-UCL.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0033268; C:node of Ranvier; IDA:BHF-UCL.
DR   GO; GO:0033010; C:paranodal junction; ISO:RGD.
DR   GO; GO:0033270; C:paranode region of axon; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0097454; C:Schwann cell microvillus; IDA:RGD.
DR   GO; GO:0098632; F:cell-cell adhesion mediator activity; IBA:GO_Central.
DR   GO; GO:0086080; F:protein binding involved in heterotypic cell-cell adhesion; ISO:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0007411; P:axon guidance; ISO:RGD.
DR   GO; GO:0007420; P:brain development; IBA:GO_Central.
DR   GO; GO:0098609; P:cell-cell adhesion; IBA:GO_Central.
DR   GO; GO:0045162; P:clustering of voltage-gated sodium channels; ISO:RGD.
DR   GO; GO:0042552; P:myelination; IEP:BHF-UCL.
DR   GO; GO:0030913; P:paranodal junction assembly; ISO:RGD.
DR   GO; GO:0007422; P:peripheral nervous system development; IEP:BHF-UCL.
DR   GO; GO:0071205; P:protein localization to juxtaparanode region of axon; ISO:RGD.
DR   GO; GO:0002175; P:protein localization to paranode region of axon; ISO:RGD.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0050808; P:synapse organization; ISO:RGD.
DR   GO; GO:0019226; P:transmission of nerve impulse; ISO:RGD.
DR   CDD; cd00063; FN3; 4.
DR   CDD; cd05731; Ig3_L1-CAM_like; 1.
DR   CDD; cd05845; IgI_2_L1-CAM_like; 1.
DR   CDD; cd05875; IgI_hNeurofascin_like; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 10.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013151; Immunoglobulin_dom.
DR   InterPro; IPR026966; Neurofascin/L1/NrCAM_C.
DR   InterPro; IPR026965; NFASC_Ig-like.
DR   PANTHER; PTHR44170:SF12; NEUROFASCIN; 1.
DR   PANTHER; PTHR44170; PROTEIN SIDEKICK; 1.
DR   Pfam; PF13882; Bravo_FIGEY; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07679; I-set; 3.
DR   Pfam; PF00047; ig; 1.
DR   Pfam; PF13927; Ig_3; 2.
DR   SMART; SM00060; FN3; 4.
DR   SMART; SM00409; IG; 6.
DR   SMART; SM00408; IGc2; 6.
DR   SUPFAM; SSF49265; Fibronectin type III; 3.
DR   SUPFAM; SSF48726; Immunoglobulin; 6.
DR   PROSITE; PS50853; FN3; 4.
DR   PROSITE; PS50835; IG_LIKE; 6.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell membrane;
KW   Disulfide bond; Glycoprotein; Immunoglobulin domain; Membrane;
KW   Phosphoprotein; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..1240
FT                   /note="Neurofascin"
FT                   /id="PRO_0000015051"
FT   TOPO_DOM        25..1110
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1111..1131
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1132..1240
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          41..137
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          143..230
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          244..332
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          337..424
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          429..517
FT                   /note="Ig-like C2-type 5"
FT   DOMAIN          521..603
FT                   /note="Ig-like C2-type 6"
FT   DOMAIN          630..725
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          727..823
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          827..922
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1007..1099
FT                   /note="Fibronectin type-III 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   REGION          710..740
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          902..942
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          982..1002
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1141..1240
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        710..729
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        902..921
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1141..1165
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1167..1188
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1211..1225
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1226..1240
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         481
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:O94856"
FT   MOD_RES         485
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O94856"
FT   MOD_RES         1160
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q810U3"
FT   MOD_RES         1174
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1187
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1190
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1226
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q810U3"
FT   MOD_RES         1227
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q810U3"
FT   MOD_RES         1231
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q810U3"
FT   CARBOHYD        305
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        409
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        446
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        483
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        752
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007744|PubMed:24090084"
FT   CARBOHYD        778
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        866
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        881
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1015
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007744|PubMed:24090084"
FT   CARBOHYD        1026
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1047
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1101
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        63..118
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        162..213
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        268..316
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        358..408
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        452..501
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        543..592
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         31..36
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:8947556, ECO:0000303|Ref.1"
FT                   /id="VSP_050416"
FT   VAR_SEQ         236
FT                   /note="T -> NNPYNDSSLRNHPDIYSA (in isoform 2 and isoform
FT                   3)"
FT                   /evidence="ECO:0000303|PubMed:8947556, ECO:0000303|Ref.1"
FT                   /id="VSP_050417"
FT   VAR_SEQ         611..625
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:8947556, ECO:0000303|Ref.1"
FT                   /id="VSP_008941"
FT   VAR_SEQ         824
FT                   /note="L -> YPRAAPTEVKIRVLNSTAISLQWNRVYPDTVQGQLREYRAYYWRESS
FT                   LLKNLWVSQKRQQASFPGDRPRGVVGRLFPYSNYKLEMVVVNGRGDGPRSETKEFTTPE
FT                   GV (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:8947556, ECO:0000303|Ref.1"
FT                   /id="VSP_050418"
FT   VAR_SEQ         928..1096
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:8947556, ECO:0000303|Ref.1"
FT                   /id="VSP_050419"
FT   CONFLICT        482
FT                   /note="E -> Q (in Ref. 2; AAB47753/AAB47754)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        675
FT                   /note="W -> L (in Ref. 2; AAB47753/AAB47754)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        699
FT                   /note="Q -> D (in Ref. 2; AAB47753/AAB47754)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        763
FT                   /note="Y -> YY (in Ref. 2; AAB47753/AAB47754)"
FT                   /evidence="ECO:0000305"
FT   HELIX           1200..1202
FT                   /evidence="ECO:0007829|PDB:7XCE"
FT   TURN            1209..1212
FT                   /evidence="ECO:0007829|PDB:7XCE"
SQ   SEQUENCE   1240 AA;  138004 MW;  636A187BC3772513 CRC64;
     MARQQAPPWV HVALILFLLS LGGAIEIPMD PSIQNELTQP PTITKQSVKD HIVDPRDNIL
     IECEAKGNPA PSFHWTRNSR FFNIAKDPRV SMRRRSGTLV IDFRSGGRPE EYEGEYQCFA
     RNKFGTALSN RIRLQVSKSP LWPKENLDPV VVQEGAPLTL QCNPPPGLPS PVIFWMSSSM
     EPITQDKRVS QGHNGDLYFS NVMLQDMQTD YSCNARFHFT HTIQQKNPFT LKVLTTRGVA
     ERTPSFMYPQ GTSSSQMVLR GMDLLLECIA SGVPTPDIAW YKKGGDLPSD KAKFENFNKA
     LRITNVSEED SGEYFCLASN KMGSIRHTIS VRVKAAPYWL DEPKNLILAP GEDGRLVCRA
     NGNPKPTVQW LVNGDPLQSA PPNPNREVAG DTIIFRDTQI SSRAVYQCNT SNEHGYLLAN
     AFVSVLDVPP RMLSPRNQLI RVILYNRTRL DCPFFGSPIP TLRWFKNGQG SNLDGGNYHV
     YENGSLEIKM IRKEDQGIYT CVATNILGKA ENQVRLEVKD PTRIYRMPED QVAKRGTTVQ
     LECRVKHDPS LKLTVSWLKD DEPLYIGNRM KKEDDSLTIF GVAERDQGSY TCMASTELDQ
     DLAKAYLTVL ADQATPTNRL AALPKGRPDR PRDLELTDLA ERSVRLTWIP GDDNNSPITD
     YVVQFEEDQF QPGVWHDHSK FPGSVNSAVL HLSPYVNYQF RVIAVNEVGS SHPSLPSERY
     RTSGAPPESN PSDVKGEGTR KNNMEITWTP MNATSAFGPN LRYIVKWRRR ETRETWNNVT
     VWGSRYVVGQ TPVYVPYEIR VQAENDFGKG PEPETVIGYS GEDLPSAPRR FRVRQPNLET
     INLEWDHPEH PNGILIGYTL RYVPFNGTKL GKQMVENFSP NQTKFSVQRA DPVSRYRFSL
     SARTQVGSGE AATEESPTPP NEATPTAAPP TLPPTTVGTT GLVSSTDATA LAATSEATTV
     PIIPTVVPTT VATTIATTTT TTAAATTTTT TESPPTTTTG TKIHETAPDE QSIWNVTVLP
     NSKWANITWK HNFRPGTDFV VEYIDSNHTK KTVPVKAQAQ PIQLTDLFPG MTYTLRVYSR
     DNEGISSTVI TFMTSTAYTN NQTDIATQGW FIGLMCAIAL LVLILLIVCF IKRSRGGKYP
     VREKKDVPLG PEDPKEEDGS FDYSDEDNKP LQGSQTSLDG TIKQQESDDS LVDYGEGGEG
     QFNEDGSFIG QYTVRKDKEE TEGNESSEAT SPVNAIYSLA
//
